| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |